Fig. 2From: Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approachExpression of circulating miRNA-26a (a), miRNA-222 (b) and miR-378a-5p (c) in plasma of LGEnegative (N = 15) and LGE-positive (N = 48) muscular dystrophy patients as well as controls (N = 26). Each miRNA plasma level was normalized to miR-16 plasma levels and thereafter multiplied by 103 in order to increase readability. LGE: late gadolinium enhancementBack to article page